[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Intra-tracheal surfactant in COVID-19 patients who are under mechanical ventilation, which includes the administration of a standard dose of surfactant inside the airway of the patient with COVID-19 diagnosis, which is administered immediately on the first day of intubation and in two doses at intervals within 6 hours. The dose of the drug is a vial containing 4 ml, equivalent to 100 mg, which is prescribed for an adult weighing about 70 kg each time, and if the patient's weight is higher, it will be adjusted accordingly. The drug is from the brand Beraksurf\u00ae and is supplied by Tekzima.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: all the treatment protocols including standard of care is the same as the treatment group; except for the intrathecal administration of surfactant. An equivalent volume of normal saline is used as placebo", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": 1249, "treatment_name": "Surfactant", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]